![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Shreis Scalene Therapeutics Plans 510(k) Filing for Coronavirus Cannon
Shreis Scalene Therapeutics Plans 510(k) Filing for Coronavirus Cannon
![ClearanceStamp_Blue.gif](https://www.fdanews.com/ext/resources/test/Device_Images6/ClearanceStamp_Blue.gif?t=1576043968&width=430)
April 20, 2021
Shreis Scalene Therapeutics has announced that it will file for 510(k) clearance from the FDA for its Scalene Hypercharge Corona Cannon (SHYCOCAN), a device intended to disable viruses, including coronaviruses.
The device disables components of the SARS-CoV-2 spike protein by bombarding the virus with trillions of electrons per second. It is intended to disable airborne and surface virus particles, the Gaithersburg, Md.-based company said.
The SHYCOCAN has previously been granted CE mark certification as a Class I device, a category of devices with the lowest perceived risk.
Upcoming Events
-
21Oct